Pfizer Announces Plans To Form $295 Million Generics JV In China
This article was originally published in PharmAsia News
Executive Summary
Pfizer and Chinese drug maker Zhejiang Hisun Pharmaceutical Co. Ltd. announce plans to establish a $295 million joint venture to sell Pfizer’s off-patent drugs in China.